Faster drug discovery through machine learning

Drugs can only work if they stick to their target proteins in the body. Assessing that stickiness is a key hurdle in the drug discovery and screening process. New research combining chemistry and machine learning could lower ...

Breast cancer-on-a-chip for testing immunotherapy drugs

There are many mechanisms by which the body responds to foreign invaders. One of these involves the T-cells of the immune system, which have a number of different proteins on their surface called 'checkpoint proteins.' These ...

Unravelling the coronavirus structure

Since the beginning of the pandemic, scientists worldwide have been working intensely to precisely characterize the novel SARS-CoV2 virus. Only by understanding in detail how the virus is constructed and how it replicates ...

When active substance and target protein 'embrace' each other

Many anti-cancer drugs block signals in cancer cells that help degenerated cells to multiply uncontrollably and detach from tissue. For example, blocking the signaling protein FAK, a so-called kinase, causes breast cancer ...

page 15 from 40